PATRICK G. ENRIGHT - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role
Director, 10%+ Owner
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
+$18,275,000
Form type
4
Filing time
05 Feb 2026, 19:03:06 UTC
Previous filing
15 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ENRIGHT PATRICK G Director, 10%+ Owner C/O LONGITUDE CAPITAL, 2740 SAND HILL ROAD, SECOND FLOOR, MENLO PARK /s/ Michael Greco, Attorney-in-Fact 05 Feb 2026 0001253886

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MANE Common Stock Conversion of derivative security +1,236,631 1,236,631 05 Feb 2026 See Footnote F1, F2
transaction MANE Common Stock Conversion of derivative security +1,171,121 +95% 2,407,752 05 Feb 2026 See Footnote F2, F3
transaction MANE Common Stock Conversion of derivative security +1,171,121 1,171,121 05 Feb 2026 See Footnote F3, F4
transaction MANE Common Stock Purchase $3,274,999 +192,647 +8% $17.00 2,600,399 05 Feb 2026 See Footnote F2
transaction MANE Common Stock Purchase $15,000,001 +882,353 +75% $17.00 2,053,474 05 Feb 2026 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MANE Series B Convertible Preferred Stock Conversion of derivative security -1,236,631 -100% 0 05 Feb 2026 Common Stock 1,236,631 See Footnote F1
transaction MANE Series C Convertible Preferred Stock Conversion of derivative security -1,171,121 -100% 0 05 Feb 2026 Common Stock 1,171,121 See Footnote F3
transaction MANE Series C Convertible Preferred Stock Conversion of derivative security -1,171,121 -100% 0 05 Feb 2026 Common Stock 1,171,121 See Footnote F3
transaction MANE Stock Option (Right to Buy) Award $0 +45,131 $0.000000 45,131 03 Feb 2026 Common Stock 45,131 $17.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F2 These shares are held by Longitude Venture Partners V, L.P. ("LVPV"). Longitude Capital Partners V, LLC ("LCPV"), is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of LCPV, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of LCPV, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
F3 On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F4 These shares are held by Longitude 103.8 East, L.P. ("L103"). Longitude 103.8 East Partners, LLC ("L103P") is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of L103P, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of L103P, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
F5 This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.